The development of pharmaceuticals derived from cannabis took a major step forward in June when the UK’s Medicines and Healthcare Products Regulatory Agency approved the prescription use of Sativex to treat spasticity due to multiple sclerosis.
New knockout rat models can be more effective predictors of pharmacokinetics.
Designing a new drug can be faster and more economical when researchers incorporate computational approaches. Software packages let scientists explore more structural options and even make predictions of the properties of new compounds.
BioTek’s Synergy 2 Alpha Microplate Reader provides high-performance Alpha detection at a reasonable price for low- to medium-throughput laboratories.
Abbott has launched Psoriasisanswers.com, a new educational Web site created to clear up the myths and provide facts and useful tools for people living with psoriasis.
Biosearch Technologies, Inc. announced that it has entered into a new license relationship with QIAGEN providing broad commercialisation rights to Scorpions Primers.
Hematopoietic stem cells have two unique abilities that are prized by medical researchers: to self-renew and to develop into any kind of blood cell, which enables them to replenish the entire blood and immune system.
A University of Florida researcher says acetaminophen, an ingredient in the popular over-the-counter pain reliever, may relieve social pain from hurt feelings. The findings suggest for the first time that emotional and physical pain are interrelated.
A rare U.S. outbreak of typhoid fever has been linked to a frozen tropical fruit product used to make smoothies, health officials reported.
The head of the U.S. Food and Drug Administration says China is improving its oversight of its exporters following a slew of scandals over bogus or substandard drugs and foods ranging from vaccines and infant formula to dog chow.
Federal health regulators are warning doctors and patients that an anti-seizure drug from GlaxoSmithKline PLC can cause rare inflammation of the brain and spinal cord.
Eli Lilly & Co. lowered its revenue outlook for the year after it lost a patent lawsuit over its attention deficit hyperactivity drug Strattera.
The Automation Partnership (TAP) has announced the launch of RAFT (Real Architecture for 3D Tissue), its innovative system for generating reproducible, 3D collagen tissue constructs.
PerkinElmer, Inc., a leader focused on health and safety, announced a free demonstration version of its universal 3D image analysis Volocity software.
GenoLogics announced it will provide the Queensland Centre for Medical Genomics with Geneus, a LIMS system that is built to enable genomics research.